Medtronic 2012 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2012 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

Investor Information
Annual Meeting and Record Dates
Medtronic, Inc.’s (Medtronic or the Company) Annual Meeting of Shareholders will be held on
Thursday, August 23, 2012 at 10:30 a.m., Central Daylight Time at the Company’s World Headquarters,
710 Medtronic Parkway, Minneapolis (Fridley), Minnesota. The record date for the Annual Meeting is
June 25, 2012 and all shareholders of record at the close of business on that day will be entitled to vote at
the Annual Meeting.
Medtronic Website
Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K,
and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 are available through our website (www.medtronic.com under the “Investors
caption and “Financial Information SEC Filings” subcaption) free of charge as soon as reasonably
practicable after we electronically file such material with, or furnish it to, the Securities and Exchange
Commission (SEC).
Information relating to corporate governance at Medtronic, including our Principles of Corporate
Governance, Code of Conduct (including our Code of Ethics for Senior Financial Officers), Code of
Business Conduct and Ethics for Members of the Board of Directors and information concerning our
executive officers, directors and Board committees (including committee charters) and transactions in
Medtronic securities by directors and officers, is available on or through our website at www.medtronic.com
under the “Investors” caption and the “Corporate Governance subcaption.
The information listed above may also be obtained upon request from the Medtronic Investor Relations
Department, 710 Medtronic Parkway, Minneapolis (Fridley), Minnesota 55432, USA.
We are not including the information on our website as a part of, or incorporating it by reference into,
our Form 10-K.
Available Information
The SEC maintains a website that contains reports, proxy and information statements, and other
information regarding issuers, including the Company, that file electronically with the SEC. The public can
obtain any documents that the Company files with the SEC at http://www.sec.gov. The Company files annual
reports, quarterly reports, proxy statements, and other documents with the SEC under the Securities
Exchange Act of 1934, as amended (Exchange Act). The public may read and copy any materials that the
Company files with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Room 1580,
Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room
by calling the SEC at 1-800-SEC-0330.
Stock Transfer Agent and Registrar
Wells Fargo Shareowner ServicesSM acts as transfer agent and registrar, dividend paying agent,
and direct stock purchase plan agent for Medtronic and maintains all shareholder records for the
Company. If you are a registered shareholder, you may access your account information online at
www.shareowneronline.com. If you have questions regarding the Medtronic stock you own, stock transfers,
address or name changes, direct deposit of dividends, lost dividend checks, lost stock certificates, or
duplicate mailings, please contact Wells Fargo Shareowner ServicesSM by writing or calling: Wells Fargo
Shareowner ServicesSM, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120 USA, Telephone:
888-648-8154 or 651-450-4064, Fax: 651-450-4033, www.wellsfargo.com/shareownerservices.
Direct Stock Purchase Plan
Medtronic’s transfer agent, Wells Fargo Shareowner ServicesSM, administers the direct stock purchase
plan, which is called the Shareowner Service Plus PlanSM. Features of this plan include direct stock purchase
and reinvestment of dividends to purchase whole or fractional shares of Medtronic stock. All registered
shareholders and potential investors may participate.